3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
INDUSTRY
3
Study Type
Observational
3
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Breast Neoplasms
694
Neoplasms
612
Prostatic Neoplasms
315
Lung Neoplasms
308
Colorectal Neoplasms
280
Carcinoma, Non-Small-Cell Lung
254
Pancreatic Neoplasms
178
Carcinoma, Hepatocellular
168
Stomach Neoplasms
139
Multiple Myeloma
127
Ovarian Neoplasms
120
Melanoma
118
Colonic Neoplasms
112
Brain Neoplasms
108
Hematologic Neoplasms
107
Head and Neck Neoplasms
106
Urinary Bladder Neoplasms
103
Leukemia, Myeloid, Acute
102
Esophageal Neoplasms
101
Disease
100
Uterine Cervical Neoplasms
88
Neoplasm Metastasis
88
Liver Neoplasms
88
Rectal Neoplasms
85
Lymphoma
84
Precursor Cell Lymphoblastic Leukemia-Lymphoma
83
Endometrial Neoplasms
76
Carcinoma, Renal Cell
73
Leukemia
63
Recurrence
62
Interventions
darolutamide
2
Docetaxel
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
1 year
×
Clear all
NCT07395804
2026-05-29
23146
Bayer
Recruiting
500 enrolled
NCT06661122
2026-05-19
HAYATE
Bayer
Recruiting
100 enrolled
NCT06010914
2026-04-15
DADOX
Bayer
Active not recruiting
100 enrolled